Dose: 4 mg
Single Dose: 4 (4)
Frequency: 24 hourly
Route: PO
Instructions: Increase by 4 to 8 mg at wk intervals until clinical response achieved.

. It is of Synthetic origin. . The Molecular Weight of Tiagabine (HCl) is 412.00.

Tiagabine (HCl)

The severe or irreversible adverse effects of Tiagabine (HCl), which give rise to further complications include Nystagmus, Tremors.The symptomatic adverse reactions produced by Tiagabine (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Diarrhea, Fever, Nervousness, Chills, Confusion, Depression, Nausea and vomiting, Bruising.

Tiagabine (HCl) is primarily indicated in conditions like Epilepsy, Refractory partial seizures.

Tiagabine (HCl) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementCarbamazepineCarbamazepine reduces plasma concentration of Tigabine.PhenobarbitonePhenytoin (Na)VORICONAZOLEVoriconazole may increase the serum concentration of tiagabine by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store at room temperature. Protect from Sunlight and Moisture.

Dosage should be reduced and/or the dosage intervals increased in patients with hepatic impairment because hepatic metabolism of tiagabine is reduced in such patients.